Fractyl Health (GUTS) Gains from Investment Securities (2023 - 2026)

Fractyl Health (GUTS) has 4 years of Gains from Investment Securities data on file, last reported at -$30.1 million in Q1 2026.

• Quarterly Gains from Investment Securities fell 3543.03% year-over-year to -$30.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$68.9 million (down 731.34% YoY) and the FY2025 annual result came in at $40.9 million, up 328.4% from the prior year.
• Gains from Investment Securities slipped to -$30.1 million in Q1 2026, from -$24.5 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $5.6 million in Q4 2023 to a low of -$30.1 million in Q1 2026.
• A 4-year average of -$6.2 million and a median of -$825000.0 in 2025 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2024 — Gains from Investment Securities sank 209020.0% — and 2025, when it jumped 107.4%.
• Tracing GUTS's Gains from Investment Securities over 4 years: stood at $5.6 million in 2023, then slumped by 108.27% to -$466000.0 in 2024, then plunged by 5159.66% to -$24.5 million in 2025, then fell by 22.62% to -$30.1 million in 2026.
• The last three Gains from Investment Securities figures came in at -$30.1 million (Q1 2026), -$24.5 million (Q4 2025), and -$14.7 million (Q3 2025), per Business Quant data.